HMG-CoA reductase and PPARalpha are involved in clofibrate-induced apoptosis in human keratinocytes

Apoptosis : an International Journal on Programmed Cell Death
Guiliana MuzioMarina Maggiora

Abstract

Contrasting data have been reported on the effects of clofibrate, a PPARalpha agonist and hypolipidemic drug. The carcinogenic and anti-apoptotic effects have been demonstrated especially in rodents in both "in vivo" and "in vitro" experiments. In contrast, in rat and human hepatoma cell lines, several reports have shown its concentration-dependent pro-apoptotic effect. No epidemiological data exist about its carcinogenetic effect in man. This study shows that clofibrate also induced apoptosis in a human non-tumour cell line, NCTC 2544, which shares the characteristic of proliferation with tumour cells. Both HMG-CoA reductase and PPARalpha were found to be involved in the signal transduction pathway inducing apoptosis, the former being the principal target: HMG-CoA reductase decreased and PPARalpha increased. Changes in HMG-CoA reductase expression caused activation of parameters leading to apoptosis via the mitochondria pathway. Clofibrate must be considered a pro-apoptotic molecule at concentrations of 0.25 mM and above: the effect is exercised not only on tumour cells but also on normal human proliferating cells. Clofibrate should thus be regarded as a potential drug to reduce the number of proliferating cells in pathologica...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M GöttlicherJ A Gustafsson
Dec 31, 1990·Biochemical and Biophysical Research Communications·M Cherkaoui MalkiN Latruffe
Jul 23, 1998·Cancer Detection and Prevention·R A CanutoF M Baccino
Dec 2, 1999·Experimental Cell Research·E S Kandel, N Hay
Mar 25, 2000·The Journal of Investigative Dermatology·M RivierS Michel
Jul 13, 2000·Human & Experimental Toxicology·V GollL Richert
Aug 22, 2000·The Journal of Investigative Dermatology·L G KömüvesK R Feingold
Jun 8, 2001·The Biochemical Journal·J P KehrerJ P Vanden Heuvel
Dec 11, 2002·The Journal of Membrane Biology·J R Silvius
Dec 31, 2002·Toxicology·R A RobertsN Macdonald
Jan 4, 2003·Archives of Pharmacal Research·Kwang-Nym Cho, Kee-In Lee
Jan 9, 2003·Journal of Lipid Research·Rosa A CanutoFrancesco M Baccino
Mar 29, 2003·Mechanisms of Ageing and Development·Jihan A YoussefMostafa Z Badr
Apr 4, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·Stéphane Kuenzli, Jean-Hilaire Saurat
Apr 18, 2003·Toxicology·Giuliana MuzioRosa Angela Canuto
Aug 29, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Nicolas Di-PoïWalter Wahli
Oct 15, 2003·The Journal of Pharmacology and Experimental Therapeutics·George W SmallRobert Z Orlowski
Aug 19, 2004·International Journal of Cancer. Journal International Du Cancer·Marina MaggioraRosa Angela Canuto
Apr 22, 2005·Apoptosis : an International Journal on Programmed Cell Death·T KubotaR Oishi
Jun 24, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ke-Jie YinChung Y Hsu
Apr 1, 1997·Cell Death and Differentiation·R A CanutoF M Baccino

❮ Previous
Next ❯

Citations

Jun 16, 2010·Lipids in Health and Disease·Rishikesh MankidyDayan B Goodenowe
Nov 6, 2008·Biochemical Pharmacology·F PennaP Costelli
Apr 7, 2009·Lasers in Surgery and Medicine·Silvia SaracinoGiuliana Muzio
Aug 11, 2007·International Journal of Cancer. Journal International Du Cancer·Giuliana MuzioRosa Angela Canuto
Sep 24, 2010·Cell Biochemistry and Function·Marina MaggioraRosa Angela Canuto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis